Obligatory role for B cells in the development of angiotensin II-dependent hypertension

Hypertension

Volumn 66, Issue 5, 2015, Pages 1023-1033

  Chan, Christopher T ^a   Sobey, Christopher G ^a   Lieu, Maggie ^a   Ferens, Dorota ^a   Kett, Michelle M ^a   Diep, Henry ^a   Kim, Hyun Ah ^a   Krishnan, Shalini M ^a   Lewis, Caitlin V ^a   Salimova, Ekaterina ^a   Tipping, Peter ^a   Vinh, Antony ^a   Samuel, Chrishan S ^a   Peter, Karlheinz ^b   Guzik, Tomasz J ^c,d   Kyaw, Tin S ^b   Toh, Ban Hock ^a   Bobik, Alexander ^b   Drummond, Grant R ^a  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

hypertension; immune system; immunology; inflammation; lymphocytes

Indexed keywords

ANGIOTENSIN II; B CELL ACTIVATING FACTOR RECEPTOR; CD20 ANTIBODY; CD86 ANTIGEN; COLLAGEN; IMMUNOGLOBULIN G; TRANSFORMING GROWTH FACTOR BETA; ANTIIDIOTYPIC ANTIBODY; CD20 ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERIAL STIFFNESS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; IMMUNOGLOBULIN G DEFICIENCY; IMMUNOGLOBULIN PRODUCTION; IMMUNOTHERAPY; LYMPHOCYTE DEPLETION; LYMPHOCYTE FUNCTION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSE WAVE; VASCULAR REMODELING; ANIMAL; CELL PROLIFERATION; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPLEEN;

ADOPTIVE TRANSFER; ANGIOTENSIN II; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, CD20; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; HYPERTENSION; IMMUNOGLOBULIN G; MICE; MICE, KNOCKOUT; SPLEEN; TRANSFORMING GROWTH FACTOR BETA; VASCULAR STIFFNESS;

EID: 84943396606     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.05779     Document Type: Article

References (51)

1. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG., Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007 204 2449 2460. doi: 10.1084/jem.20070657
2. Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ, Harrison DG., Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010 55 500 507. doi: 10.1161/HYPERTENSIONAHA.109.145094
3. Barhoumi T, Kasal DA, Li MW, Shbat L, Laurant P, Neves MF, Paradis P, Schiffrin EL., T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 2011 57 469 476. doi: 10.1161/HYPERTENSIONAHA.110.162941
4. Matrougui K, Abd Elmageed Z, Zakaria AE, Kassan M, Choi S, Nair D, Gonzalez-Villalobos RA, Chentoufi AA, Kadowitz P, Belmadani S, Partyka M., Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice. Am J Pathol 2011 178 434 441. doi: 10.1016/j.ajpath.2010.11.034
5. LeBien TW, Tedder TF., B lymphocytes: how they develop and function. Blood 2008 112 1570 1580. doi: 10.1182/blood-2008-02-078071
6. Martinez FO, Gordon S., The M1 and M2 paradigm of macrophage activation: Time for reassessment. F1000Prime Rep 2014 6 13. doi: 10.12703/P6-13
7. Allen LA, Aderem A., Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages. J Exp Med 1996 184 627 637
8. Dunkelberger JR, Song WC., Complement and its role in innate and adaptive immune responses. Cell Res 2010 20 34 50. doi: 10.1038/cr.2009.139
9. Ebringer A, Doyle AE., Raised serum IgG levels in hypertension. Br Med J 1970 2 146 148
10. Suryaprabha P, Padma T, Rao UB., Increased serum IgG levels in essential hypertension. Immunol Lett 1984 8 143 145
11. Hilme E, Herlitz H, Söderström T, Hansson L., Increased secretion of immunoglobulins in malignant hypertension. J Hypertens 1989 7 91 95
12. Gudbrandsson T, Hansson L, Herlitz H, Lindholm L, Nilsson LA., Immunological changes in patients with previous malignant essential hypertension. Lancet 1981 1 406 408
13. Chen CM, Schachter D., Elevation of plasma immunoglobulin A in the spontaneously hypertensive rat. Hypertension 1993 21 731 738
14. Sasaki Y, Casola S, Kutok JL, Rajewsky K, Schmidt-Supprian M., TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol 2004 173 2245 2252
15. Agabiti-Rosei E, Muiesan ML., Cardiac hypertrophy and hypertension. Curr Opin Nephrol Hypertens 1998 7 211 216
16. Suvas S, Singh V, Sahdev S, Vohra H, Agrewala JN., Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J Biol Chem 2002 277 7766 7775. doi: 10.1074/jbc.M105902200
17. Subauste CS, De Waal Malefyt R, Fuh F., Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen. J Immunol 1998 160 1831 1840
18. Parker DC., T cell-dependent B cell activation. Annu Rev Immunol 1993 11 331 360. doi: 10.1146/annurev.iy.11.040193.001555
19. Wenzel P, Knorr M, Kossmann S, Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Circulation 2011 124 1370 1381. doi: 10.1161/CIRCULATIONAHA.111.034470
20. Moore JP, Vinh A, Tuck KL, Sakkal S, Krishnan SM, Chan CT, Lieu M, Samuel CS, Diep H, Kemp-Harper BK, Tare M, Ricardo SD, Guzik TJ, Sobey CG, Drummond GR., M2 macrophage accumulation in the aortic wall during angiotensin ii infusion in mice is associated with fibrosis, elastin loss and elevated blood pressure [published online ahead of print June 12, 2015]. Am J Physiol Heart Circ Physiol. doi: 10.1152/ajpheart.00821.2014. http://ajpheart.physiology.org/content/early/2015/06/09/ajpheart.00821.2014.article-info. Accessed June 15, 2015
21. Sica A, Mantovani A., Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012 122 787 795. doi: 10.1172/JCI59643
22. Vogelpoel LT, Hansen IS, Rispens T, Muller FJ, Van Capel TM, Turina MC, Vos JB, Baeten DL, Kapsenberg ML, De Jong EC, den Dunnen J., Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun 2014 5 5444. doi: 10.1038/ncomms6444
23. Vinh A, Chen W, Blinder Y, Weiss D, Taylor WR, Goronzy JJ, Weyand CM, Harrison DG, Guzik TJ., Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation 2010 122 2529 2537. doi: 10.1161/CIRCULATIONAHA.109.930446
24. Payne RA, Wilkinson IB, Webb DJ., Arterial stiffness and hypertension: emerging concepts. Hypertension 2010 55 9 14. doi: 10.1161/HYPERTENSIONAHA.107.090464
25. Khalil N, Bereznay O, Sporn M, Greenberg AH., Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989 170 727 737
26. Di Lascio N, Stea F, Kusmic C, Sicari R, Faita F., Non-invasive assessment of pulse wave velocity in mice by means of ultrasound images. Atherosclerosis 2014 237 31 37. doi: 10.1016/j.atherosclerosis.2014.08.033
27. Ramos-Casals M, Sanz I, Bosch X, Stone JH, Khamashta MA., B-cell-depleting therapy in systemic lupus erythematosus. Am J Med 2012 125 327 336. doi: 10.1016/j.amjmed.2011.09.010
28. Mond JJ, Lees A, Snapper CM., T cell-independent antigens type 2. Annu Rev Immunol 1995 13 655 692. doi: 10.1146/annurev.iy.13.040195.003255
29. Chan CT, Lieu M, Toh BH, Kyaw TS, Bobik A, Sobey CG, Drummond GR., Antibodies in the pathogenesis of hypertension. Biomed Res Int 2014 2014 504045. doi: 10.1155/2014/504045
30. Harvey BP, Gee RJ, Haberman AM, Shlomchik MJ, Mamula MJ., Antigen presentation and transfer between B cells and macrophages. Eur J Immunol 2007 37 1739 1751. doi: 10.1002/eji.200636452
31. Zouggari Y, Ait-Oufella H, Bonnin P, B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med 2013 19 1273 1280. doi: 10.1038/nm.3284
32. O'Connell FP, Pinkus JL, Pinkus GS., CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. Am J Clin Pathol 2004 121 254 263. doi: 10.1309/617D-WB5G-NFWX-HW4L.
33. Shapiro-Shelef M, Calame K., Regulation of plasma-cell development. Nat Rev Immunol 2005 5 230 242. doi: 10.1038/nri1572
34. Michaelsen TE, Kolberg J, Aase A, Herstad TK, Høiby EA., The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis. Scand J Immunol 2004 59 34 39
35. Mackay F, Browning JL., BAFF: A fundamental survival factor for B cells. Nat Rev Immunol 2002 2 465 475. doi: 10.1038/nri844
36. Ye Q, Wang L, Wells AD, Tao R, Han R, Davidson A, Scott ML, Hancock WW., BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses. Eur J Immunol 2004 34 2750 2759. doi: 10.1002/eji.200425198
37. Lagresle-Peyrou C, Yates F, Malassis-Séris M, Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: A balance between efficiency and toxicity. Blood 2006 107 63 72. doi: 10.1182/blood-2005-05-2032
38. Fu ML, Herlitz H, Schulze W, Wallukat G, Micke P, Eftekhari P, Sjögren KG, Hjalmarson A, Müller-Esterl W, Hoebeke J., Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens 2000 18 945 953
39. Liao YH, Wei YM, Wang M, Wang ZH, Yuan HT, Cheng LX., Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension. Hypertens Res 2002 25 641 646
40. Wallukat G, Blasig IE, Morwinski R, Herrmann HJ, Rohde E., The sera of spontaneously hypertensive rats contain agonistic auto-antibodies against the beta 1-adrenoceptor. J Hypertens 1995 13 1031 1036
41. Zhou ZH, Wang J, Xiao H, Chen ZJ, Wang M, Cheng X, Liao YH., A novel autoantibody in patients with primary hypertension: Antibody against L-type Ca2+ channel. Chin Med J (Engl) 2008 121 1513 1517
42. Mathis KW, Wallace K, Flynn ER, Maric-Bilkan C, LaMarca B, Ryan MJ., Preventing autoimmunity protects against the development of hypertension and renal injury. Hypertension 2014 64 792 800. doi: 10.1161/HYPERTENSIONAHA.114.04006
43. Takagi M, Kimura K, Atarashi K, Ikeda T, Matsuoka H, Ishii M, Sugimoto T., Immunohistochemical study of vascular lesions in severe hypertension induced by DOCA and salt administration to spontaneously hypertensive rats. Am J Hypertens 1990 3 838 845
44. Nimmerjahn F, Ravetch JV., Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008 8 34 47. doi: 10.1038/nri2206
45. Krishnan SM, Sobey CG, Latz E, Mansell A, Drummond GR., IL-1β and IL-18: inflammatory markers or mediators of hypertension? Br J Pharmacol 2014 171 5589 5602. doi: 10.1111/bph.12876
46. Krishnan SM, Dowling J, Ling YH, Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice [published online ahead of print July 31, 2015]. Br J Pharmacol. doi: 10.1111/bph.13230. http://onlinelibrary.wiley.com/doi/10.1111/bph.13230/abstract;jsessionid=462DD7986344771AD7ACC8A5AC361CEF.f03t02. Accessed July 31, 2015
47. Wu J, Thabet SR, Kirabo A, Trott DW, Saleh MA, Xiao L, Madhur MS, Chen W, Harrison DG., Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase. Circ Res 2014 114 616 625. doi: 10.1161/CIRCRESAHA.114.302157
48. Cecelja M, Chowienczyk P., Role of arterial stiffness in cardiovascular disease. JRSM Cardiovasc Dis 2012 1:11-22. doi: 10.1258/cvd.2012.012016
49. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M., Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013 229 176 185. doi: 10.1002/path.4133
50. Ricardo SD, Van Goor H, Eddy AA., Macrophage diversity in renal injury and repair. J Clin Invest 2008 118 3522 3530. doi: 10.1172/JCI36150
51. Pimenta E, Calhoun DA., Resistant hypertension: incidence, prevalence, and prognosis. Circulation 2012 125 1594 1596. doi: 10.1161/CIRCULATIONAHA.112.097345